Loading organizations...
Maven Investment Partners Ltd operates as a proprietary trading firm, deploying internal capital across discretionary, systematic, and market-making strategies. It leverages advanced technology and quantitative models for high-frequency and strategic trades. This approach facilitates efficient price discovery and enhanced liquidity in global financial markets, delivering consistent returns through precise execution.
Incorporated in February 2011, Maven Investment Partners Ltd is a core entity of the Maven Securities group. Co-founders Ian Mark Toon and Ivan Ivanov Koedjikov, leveraging extensive financial expertise, established the firm. Their insight combined rigorous quantitative analysis, disciplined risk management, and cutting-edge technology to drive market efficiency and consistent returns. Trading began in August 2011.
As a proprietary firm, Maven Investment Partners directly engages financial markets, participating across exchanges. Its sophisticated strategies enhance market efficiency by providing consistent liquidity. The firm’s long-term vision focuses on continuous innovation in trading technology, striving to improve markets through enhanced transparency and optimal capital allocation, fostering robust trading environments.
Maven Investment Partners has 1 tracked investment across 1 company. The latest tracked deal is $84.0M Other Equity in MedAvail in November 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 18, 2020 | MedAvail | $84.0M Other Equity | Frank YU | Adage Capital Management, Cigna Ventures, Cowen Healthcare Investments, Heights Capital Management, Lewis & Clark Ventures, Pura Vida Investments, Redmile Group |